Mainit, Rosety-an O.

HRN: 18-85-55  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CEFUROXIME 1.5GM (VIAL)
05/30/2022
05/31/2022
IVT
1.5gm
IVT Now Then Q8 X 2 More Doses
Primary LTCS With PPIUD
Waiting Final Action 
05/31/2022
CEFUROXIME 500MG (TAB)
05/31/2022
06/07/2022
PO
500g
Q12
Post Op Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: